Does clozapine require REMS?
Pharmacists dispense clozapine without a REMS dispense authorization (RDA).
What should you monitor when taking clozapine?
Patients taking clozapine should receive routine weekly-to-monthly monitoring and maintain an ANC ≥1500/microL (≥1000/microL for benign ethnic neutropenia). Lower ANC levels require more frequent monitoring, and possible interruption of clozapine and/or reevaluation of its use.
Why are there new clozapine REMS?
“The purpose of this new Clozapine REMS Program is to ensure that the benefits of a patient taking clozapine are greater than the potential life threatening risk of severe neutropenia, a well established rare adverse event,” said John J. Miller, MD, Editor in Chief of Psychiatric TimesTM.
When does New clozapine REMS start?
On July 29, 2021, FDA approved a modification to the Clozapine REMS. The modification to Clozapine REMS will go into effect on November 15, 2021. Important changes include: All prescribers and pharmacies must be re-certified by November 15, 2021, or they will no longer be able to prescribe/dispense clozapine.
What is REMS number?
Call our toll free number 1-866-495-0654 to report any of the following: An Adverse Event: If you or someone you know has experienced an adverse event, please call 1-866-495-0654. A Pregnancy: If you are an activated prescriber, report pregnancy results by logging in and clicking on “Manage Patients.”
What are REMS programs?
A Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program that the U.S. Food and Drug Administration (FDA) can require for certain medications with serious safety concerns to help ensure the benefits of the medication outweigh its risks.
Does clozapine require blood profile monitoring?
In the United States, the Food and Drug Administration requires regular blood count monitoring of all patients taking clozapine. An uncommon but serious side effect of clozapine is severe neutropenia, defined as an absolute neutrophil count (ANC) less than 500/μL.
Why is clozapine so closely monitored?
Clozapine is an atypical antipsychotic that is used for treatment-resistant schizophrenia. The drug is subject to strict monitoring requirements because it is associated with serious side effects, such as neutropenia, agranulocytosis, seizures, myocarditis and cardiomyopathy.
When do you stop clozapine agranulocytosis?
When to discontinue clozapine treatment permanently Agranulocytosis, (ANC less than 500/µL) should always lead to prompt permanent discontinuation of clozapine1. If myocarditis is suspected, and troponin is more than twice the upper limit of normal or CRP is over 100 mg/L, clozapine should be discontinued permanently.
What is REMS program?
When is a REMS required?
A REMS is required to ensure the drug is administered only in a health care facility with personnel trained to manage severe allergic reactions and immediate access to necessary treatments and equipment to managing such events.
What is REMS requirement?